Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial

被引：7

作者：

Guttman-Yassky, E. ^{[1
,9
]}

Bahadori, L. ^{[2
]}

Brooks, L. ^{[3
]}

Clark, K. L. ^{[3
]}

Grindebacke, H. ^{[4
]}

Ho, C. N. ^{[5
]}

Katial, R. ^{[6
,7
]}

Pham, T. -H. ^{[8
]}

Walton, C. ^{[3
]}

Datto, C. J. ^{[2
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY USA

[2] AstraZeneca, Late Stage Dev Resp & Immunol, BioPharmaceut R&D, Gaithersburg, MD USA

[3] AstraZeneca, Late Stage Dev Resp & Immunol, BioPharmaceut R&D, Cambridge, England

[4] AstraZeneca, Late Stage Dev Resp & Immunol, BioPharmaceut R&D, Gothenburg, Sweden

[5] AstraZeneca, Patient Ctr Sci, BioPharmaceut Med, Gaithersburg, MD USA

[6] AstraZeneca, BioPharmaceut Med, Gaithersburg, MD USA

[7] Natl Jewish Hlth, Denver, CO USA

[8] AstraZeneca, Translat Sci & Expt Med, Early Resp & Immunol, BioPharmaceut R&D, Gaithersburg, MD USA

[9] Icahn Sch Med Mt Sinai, Kimberly & Er J Waldman Dept Dermatol, 1425 Madison Ave,Box 1047, New York, NY 10029 USA

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2023年 / 37卷 / 10期

关键词：

EFFICACY; SAFETY;

D O I：

10.1111/jdv.19195

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E1211 / E1214

页数：4

共 50 条

[31] Azathioprine in severe adult atopic dermatitis: A double-blind, placebo-controlled, crossover trial
Graham-Brown, RA
Takwale, A
Tan, E
Barclay, G
Agarwal, S
Ahmed, I
Hotchkiss, K
Berth-Jones, J
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 343 - 343
[32] Spesolimab, an anti-interleukin-36 receptor antibody, in patients with moderate-to-severe atopic dermatitis: Results from a multicentre, randomized, double-blind, placebo-controlled, phase IIa study
Bissonnette, Robert
Abramovits, William
Proulx, Etienne Saint-Cyr
Lee, Patricia
Guttman-Yassky, Emma
Zovko, Elizabeta
Sigmund, Ralf
Willcox, Joanne
Bieber, Thomas
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (03) : 549 - 557
[33] Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study
Gooderham, Melinda
Guttman-Yassky, Emma
Igawa, Ken
Kabashima, Kenji
Esfandiari, Ehsanollah
Rylands, Angela J.
Williams, Angela
Nixon, Annabel
Dent, Jennifer E.
Simpson, Eric
DERMATOLOGY AND THERAPY, 2024, 14 (12) : 3351 - 3366
[34] DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF LOCAL CYCLOSPORINE IN ATOPIC-DERMATITIS
DEPROST, Y
BODEMER, C
TEILLAC, D
ARCHIVES OF DERMATOLOGY, 1989, 125 (04) : 570 - 570
[35] Randomized, double-blind, placebo-controlled trial of autologous blood therapy for atopic dermatitis
Pittler, MH
Armstrong, NC
Cox, A
Collier, PM
Hart, A
Ernst, E
BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (02) : 307 - 313
[36] RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF LOCAL CYCLOSPORINE IN ATOPIC-DERMATITIS
DEPROST, Y
BODEMER, C
TEILLAC, D
ACTA DERMATO-VENEREOLOGICA, 1989, : 136 - 138
[37] Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial
Merola, Joseph F.
Parish, Lawrence Charles
Guenther, Lyn
Lynde, Charles
Lacour, Jean -Philippe
Staubach, Petra
Cheng, Sue
Paris, Maria
Picard, Hernan
Deignan, Cynthia
Jardon, Shauna
Chen, Mindy
Papp, Kim A.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (03) : 485 - 493
[38] Rocatinlimab significantly improves clinical responses in patients with moderate-to-severe atopic dermatitis by week 2 in a randomized double-blind placebo-controlled phase 2b study
Guttman-Yassky, Emma
Esfandiari, Ehsanollah
Mano, Hirotaka
Arai, Takahiro
Kabashima, Kenji
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
[39] DUPILUMAB TREATMENT IN PATIENTS WITH ATOPIC HAND AND FOOT DERMATITIS: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Simpson, Eric L.
Silverberg, Jonathan I.
Worm, Margitta
Honari, Golara
Masuda, Koji
Schuttelaar, Marie-Louise A.
Maloney, Jennifer
Xiao, Jing
Dubost-Brama, Ariane
Bansal, Ashish
ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 53 - 54
[40] Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
Simpson, Eric L.
Merola, Joseph F.
Silverberg, Jonathan, I
Reich, Kristian
Warren, Richard B.
Staumont-Salle, Delphine
Girolomoni, Giampiero
Papp, Kim
de Bruin-Weller, Marjolein
Thyssen, Jacob P.
Zachariae, Rebecca
Olsen, Christiana K.
Wollenberg, Andreas
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (06) : 888 - 899

← 1 2 3 4 5 →